Eli Lilly has announced a significant investment of at least $27 billion to establish four new manufacturing facilities in the United States over the next five years, creating over 3,000 skilled jobs and 10,000 construction positions. The move comes amid potential import duties imposed by the Trump administration and aims to bolster domestic drug production.
About the Author
